TDP-43 based biomarker development in amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis is a devastating neurodegenerative disease which is clinically and aetiologically heterogenous. However, TDP-43 neuropathology is a unifying hallmark found in 97% of ALS cases. Understanding the common pathological pathways downstream of TDP-43 dysregulation is essentia...
Main Author: | Feneberg, E |
---|---|
Other Authors: | Turner, M |
Format: | Thesis |
Language: | English |
Published: |
2019
|
Subjects: |
Similar Items
-
Heterogeneity of cortical pTDP-43 inclusion morphologies in amyotrophic lateral sclerosis
by: Rachel H. Tan, et al.
Published: (2023-11-01) -
Advancements in TDP-43 research: Towards biomarkers and therapeutic targets for amyotrophic lateral sclerosis
by: Yuhan Wu, et al.
Published: (2025-03-01) -
The role of TDP-43 protein in amyotrophic lateral sclerosis
by: Piotr Włodarczyk, et al.
Published: (2022-12-01) -
Kinesitherapy in amyotrophic lateral sclerosis
by: Joanna Iłżecka
Published: (2017-12-01) -
Kinesitherapy in amyotrophic lateral sclerosis
by: Joanna Iłżecka
Published: (2017-12-01)